Schedule 13D ownership disclosure

Kyverna Therapeutics, Inc.

Security class unavailable · CUSIP: 501976104

Event date: 2024-02-12

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
4,777,060
Percent of class
11.1000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001999371-24-005643
Form type
SC 13D
Filer
Kyverna Therapeutics, Inc.
CIK
CIK 1994702
Filed
May 03, 2024
Reporting period
Feb 12, 2024
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub